---
audienceLevel: patient
cancerTypes:
- colorectal
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Panitumumab - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/panitumumab
version: v1
---

# Panitumumab - NCI

# Panitumumab

Placeholder slot

(PAN-ih-TOO-myoo-mab)

This page contains brief information about panitumumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Vectibix

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0fa4bca-f245-4d92-ae29-b0c630a315c2&audience=consumer)

## Use in Cancer

Panitumumab is approved to treat adults with:

- **[Colorectal cancer](/Common/PopUps/popDefinition.aspx?id=444983&version=Patient&language=English)** that has spread to other parts of the body. It is used:
- with [FOLFOX](/Common/PopUps/popDefinition.aspx?id=346521&version=Patient&language=English) combination chemotherapy as the first treatment in patients whose cancer does not have an abnormal *[RAS](/Common/PopUps/popDefinition.aspx?id=45859&version=Patient&language=English)* gene
- alone in patients whose cancer does not have an abnormal *RAS* gene and got worse after treatment with chemotherapy that contained [oxaliplatin](/Common/PopUps/popDefinition.aspx?id=45465&version=Patient&language=English), [irinotecan hydrochloride](/Common/PopUps/popDefinition.aspx?id=635811&version=Patient&language=English), and a [fluoropyrimidine](/Common/PopUps/popDefinition.aspx?id=386207&version=Patient&language=English)
- with [sotorasib](/Common/PopUps/popDefinition.aspx?id=805452&version=Patient&language=English) for the treatment of patients with an abnormal *[KRAS](/Common/PopUps/popDefinition.aspx?id=652256&version=Patient&language=English)* gene who have received chemotherapy that included a fluoropyrimidine,
oxaliplatin, and irinotecan hydrochloride

Panitumumab is also being studied in the treatment of other types of cancer.

## More About Panitumumab

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/37857) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Panitumumab](https://medlineplus.gov/druginfo/meds/a607066.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

[Monoclonal Antibodies](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Panitumumab](https://www.cancer.gov/research/participate/clinical-trials/intervention/C1857) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
